A comprehensive, evidence-based educational tool for understanding organ dysfunction assessment in sepsis, based on Sepsis-3 definitions and the Surviving Sepsis Campaign Guidelines 2021.
Learn about sepsis, Sepsis-3 criteria, and the evolution of organ dysfunction assessment tools in critical care.
Complete breakdown of the Sequential Organ Failure Assessment score with all six organ system parameters.
Quick bedside assessment tool for identifying patients at risk outside the ICU setting.
Calculate SOFA and qSOFA scores with instant mortality risk interpretation and clinical guidance.
Sepsis-3 Definition (2016): Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Organ dysfunction is identified by an acute change of ≥2 points in the total SOFA score consequent to infection. The baseline SOFA score is assumed to be zero in patients without preexisting organ dysfunction.
Understanding the pathophysiology and clinical assessment of sepsis and septic shock according to current evidence-based guidelines.
Life-threatening organ dysfunction caused by a dysregulated host response to infection. Clinically operationalized as infection with an acute increase in SOFA score ≥2 points. A SOFA score ≥2 reflects an overall mortality risk of approximately 10% in hospitalized patients with suspected infection.
A subset of sepsis with profound circulatory, cellular, and metabolic abnormalities. Clinically identified by: Sepsis + need for vasopressors to maintain MAP ≥65 mmHg + serum lactate >2 mmol/L despite adequate fluid resuscitation. Hospital mortality exceeds 40%.
| Aspect | Previous (SIRS-based) | Current (Sepsis-3) |
|---|---|---|
| Sepsis Definition | SIRS + Infection | Infection + SOFA ≥2 |
| Assessment Tool | SIRS criteria (Temperature, HR, RR, WBC) | SOFA score (6 organ systems) |
| Focus | Inflammatory response | Organ dysfunction |
| Bedside Tool | SIRS | qSOFA |
| Specificity | Low (over-sensitive) | Higher (more specific) |
Designed for ICU patients to assess organ dysfunction severity and track progression. Requires laboratory data. Better for diagnosis and prognosis in critically ill patients.
Quick bedside screening tool for patients outside the ICU. Identifies high-risk patients who may have sepsis and need closer monitoring or ICU admission.
The Surviving Sepsis Campaign 2021 recommends against using qSOFA alone as a screening tool. Use in combination with other tools (NEWS, MEWS, clinical judgment).
SOFA has higher discriminative ability (AUC 0.89) for predicting sepsis compared to SIRS, qSOFA, or qSOFA+Lactate. Better mortality prediction in ICU settings.
Sequential Organ Failure Assessment - A comprehensive evaluation of six organ systems to quantify organ dysfunction severity in critically ill patients.
The SOFA score ranges from 0 to 24 points, assessing six organ systems. Each system is scored 0-4, with higher scores indicating more severe dysfunction. A SOFA ≥2 in the presence of infection defines sepsis. The score should be calculated on ICU admission and every 24 hours thereafter.
| Organ System | 0 | 1 | 2 | 3 | 4 |
|---|---|---|---|---|---|
| ≥400 | <400 | <300 | <200 (with respiratory support) |
<100 (with respiratory support) |
|
| ≥150 | <150 | <100 | <50 | <20 | |
| <1.2 | 1.2–1.9 | 2.0–5.9 | 6.0–11.9 | ≥12.0 | |
| No hypotension | MAP <70 mmHg |
Dopamine ≤5 or Dobutamine (any dose)* |
Dopamine >5 or Epi ≤0.1 or Norepi ≤0.1* |
Dopamine >15 or Epi >0.1 or Norepi >0.1* |
|
| 15 | 13–14 | 10–12 | 6–9 | <6 | |
| <1.2 | 1.2–1.9 | 2.0–3.4 | 3.5–4.9 or UO <500 mL/day |
≥5.0 or UO <200 mL/day |
*Vasopressor doses in µg/kg/min administered for at least 1 hour
SOFA 0-6: <10% mortality
SOFA 7-9: 15-20%
SOFA 10-12: 40-50%
SOFA >11: ~90% mortality
Serial SOFA scores (ΔSOFA) track disease progression. Increasing scores indicate worsening organ dysfunction and higher mortality risk.
Requires: PaO₂, FiO₂, Platelet count, Bilirubin, Creatinine. Clinical: MAP, vasopressor doses, GCS, urine output.
Quick Sequential Organ Failure Assessment - A simple bedside tool to identify patients with suspected infection who are at greater risk for poor outcomes outside the ICU.
qSOFA is a screening prompt, not a diagnostic tool. A score of ≥2 points near the onset of infection is associated with greater risk of death or prolonged ICU stay. It identifies patients who may be septic and warrant further assessment, but should NOT be used alone for sepsis screening (SSC 2021).
Systolic blood pressure at or below 100 mmHg
Respiratory rate of 22 breaths per minute or higher
Any alteration in mental status (Glasgow Coma Scale below 15)
SSC 2021 Guideline: The Surviving Sepsis Campaign recommends against using qSOFA as a single screening tool compared with SIRS, NEWS, or MEWS. qSOFA is more specific but less sensitive than SIRS for early identification of infection-induced organ dysfunction. Neither tool is ideal alone - clinical judgment remains essential.
• No laboratory tests needed
• Quick bedside assessment
• High specificity
• Good for ED/ward settings
• Identifies high-risk patients
• Lower sensitivity than SIRS
• May miss early sepsis
• Not a diagnostic tool
• Should not be used alone
• Less validated in low-resource settings
qSOFA ≥2: 3-14 fold increase in mortality risk outside ICU. 24% of infected patients with qSOFA 2-3 accounted for 70% of deaths in validation cohorts.
| Feature | qSOFA | SIRS | NEWS/MEWS |
|---|---|---|---|
| Components | SBP, RR, GCS | Temp, HR, RR, WBC | RR, SpO₂, Temp, SBP, HR, Consciousness |
| Lab Required | No | Yes (WBC) | No |
| Sensitivity | Lower | Higher | Variable |
| Specificity | Higher | Lower | Variable |
| Best Setting | ED, Ward | Any | Ward monitoring |
Calculate SOFA and qSOFA scores with instant mortality risk interpretation and clinical guidance.
Systolic Blood Pressure ≤100 mmHg
Respiratory Rate ≥22 breaths/min
Glasgow Coma Scale <15
qSOFA ≥2: Prompt further organ function assessment, consider ICU admission, initiate Hour-1 bundle if sepsis confirmed. qSOFA <2: Does not rule out sepsis - continue clinical monitoring and combine with other assessment tools.
Evidence-based approach to managing patients with suspected sepsis based on SOFA/qSOFA assessment, following the Surviving Sepsis Campaign Guidelines 2021.
Patient with suspected infection presents. Perform rapid bedside assessment:
Obtain labs to calculate full SOFA score and guide management:
Initiate within 1 hour for sepsis/septic shock (SSC 2021):
If septic shock criteria met (MAP <65 despite fluids AND lactate >2 mmol/L):
Serial assessment to track response and guide therapy:
Address infection source and optimize therapy:
• Fluid resuscitation: 30 mL/kg downgraded from strong to weak recommendation
• Balanced crystalloids suggested over normal saline
• Peripheral vasopressors: Acceptable to start peripherally rather than delaying for central access
• Corticosteroids: Suggested for ongoing vasopressor requirement
• qSOFA: Recommended against as sole screening tool